Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

SHA:603392 Revenue

Beijing Wantai Biological Pharmacy Enterprise had revenue of 523.34M CNY in the quarter ending March 31, 2026, with 30.63% growth. This brings the company's revenue in the last twelve months to 1.94B, up 2.54% year-over-year. In the year 2025, Beijing Wantai Biological Pharmacy Enterprise had annual revenue of 1.82B, down -18.99%.

• Revenue (ttm): 1.94B
• Revenue Growth: +2.54%
• P/S Ratio: 25.94
• Revenue / Employee: 471.74K
• Employees: 4,116
• Market Cap: 50.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.82B	-426.44M	-18.99%
Dec 31, 2024	2.25B	-3.27B	-59.25%
Dec 31, 2023	5.51B	-5.67B	-50.73%
Dec 31, 2022	11.19B	5.43B	94.51%
Dec 31, 2021	5.75B	3.40B	144.25%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 3, 2026

Data Sources Report a data error